Login Register Cart 0
Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Regulate the Brain Tau Hyperphosphorylation at Multiple Sites Induced by Composited Aβ in Rats

Author(s): Ding Shengkai and Shang Yazhen*

Volume 21, Issue 4, 2022

Published on: 02 January, 2021

Page: [367 - 374] Pages: 8

DOI: 10.2174/1871527320666210827112609

Price: $65

Abstract

Background: Neurofibrillary Tangles (NFTs), formed by hyperphosphorylation of Tau protein in Alzheimer's Disease (AD), arethe main pathomechanisms of neuronal degeneration, which indicate a sign of brain disorder. NFTs are positively correlated with the degree of cognitive impairment in AD.

Objective: The objective of this study isto investigate the effect of flavonoids from the stems and leaves of Scutellaria baicalensis Georgi (SSF) on the hyperphosphorylated expression levels at multiple sites of Tau protein induced by β-amyloid protein 25-35 (Aβ25-35) in combination with aluminum trichloride (AlCl3) and recombinant human transforming growth factor-β1(RHTGF-β1) (composited Aβ) in rats.

Methods: The AD rat models were established by intracerebroventricular injection of Aβ25-35 and AlCl3 combined with RHTGF-β1. On day 45, after the operation, the Morris water maze test was conducted to screen the memory impairment of AD models. The successful model rats were randomly divided into the model group and the three-dose drug group. The drug group rats were orally administered SSF daily for 38 days. Western blotting was performed to detect the protein expression of P-Tau (Thr 181), P-Tau (Thr 217), P-Tau (Thr 231), P-Tau (Ser 199), P-Tau (Ser 235), P-- Tau (Ser 396), and P-Tau (Ser 404) in the hippocampus and cerebral cortex of rats.

Results: Compared with the sham group, the expression of P-Tau (Thr 181), P-Tau (Thr 217), P-- Tau (Thr 231), P-Tau (Ser 199), P-Tau (Ser 235), P-Tau (Ser 396), and P-Tau (Ser 404)was significantly increased in the hippocampus and cerebral cortex of the model group (P < 0.01). However, the three doses of SSF, i.e., 35, 70, and 140 mg/kg, regulated the expression of phosphorylated Tau proteinto varying degrees in the hippocampus and cerebral cortex of AD model rats (P < 0.01).

Conclusion: SSF could significantly reduce the protein expression levels of P-Tau (Thr 181), PTau (Thr 217), P-Tau (Thr 231), P-Tau (Ser 199), P-Tau (Ser 235), P-Tau (Ser 396), and P-Tau (Ser 404), induced by the intracerebroventricular injection of composited Aβ, in rats’ brain. These results indicated that the neuro-protection and the improvement in the impaired memory of rats by SSF were due to the inhibition of hyperphosphorylation of Tau protein at multiple sites in rats' brain.

Keywords: Scutellaria baicalensis georgi, flavonoids, Alzheimer's disease, tau protein, hyperphosphorylation, neurofibrillary tangles (NFTs).

« Previous
Graphical Abstract

[1]
Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement 2020; 16(3): 391-460.
[http://dx.doi.org/10.1002/alz.12068] [PMID: 32157811]
[2]
Ma RH, Zhang Y, Hong XY, Zhang JF, Wang JZ, Liu GP. Role of microtubule-associated protein tau phosphorylation in Alzheimer’s disease. J Huazhong Univ Sci Technolog Med Sci 2017; 37(3): 307-12.
[http://dx.doi.org/10.1007/s11596-017-1732-x] [PMID: 28585125]
[3]
Li Y, Wen G, Ding R, et al. Effects of single-dose and long-term ketamine administration on Tau phosphorylation-related enzymes GSK-3β, CDK5, PP2A, and PP2B in the mouse hippocampus. J Mol Neurosci 2020; 70(12): 2068-76.
[http://dx.doi.org/10.1007/s12031-020-01613-9] [PMID: 32705526]
[4]
Gao Y, Wang XQ, Ma S, Dong YC, Shang YZ. Flavonoids from stem and Leaf of Scutellaria baicalonsis Georgi inhibit the phosphorylation on multi-sites of Tau protein induced by okadaic acid and the regulative mechanism of protein kinases in rats. Comb Chem High Throughput Screen 2020; 24(7): 1126-36.
[http://dx.doi.org/10.2174/1386207323666200901101233] [PMID: 32875975]
[5]
Li Y. Establishment of experimental models for Alzheimer’s disease research. Int J Neurosci 2013; 123(12): 823-31.
[http://dx.doi.org/10.3109/00207454.2013.804821] [PMID: 23668838]
[6]
Deng T, Yu ZJ, Xu Y, et al. Research progress on establishment and evaluation methods of AD cellular models. Acta Pharmacol Sin 2020; 36(4): 470-5.
[7]
Xiaoguang W, Jianjun C, Qinying C, Hui Z, Lukun Y, Yazhen S. Establishment of a valuable mimic of Alzheimer’s disease in rat animal model by intracerebroventricular injection of composited amyloid Beta protein. J Vis Exp 2018; (137): 56157.
[http://dx.doi.org/10.3791/56157] [PMID: 30102270]
[8]
Shang YZ, Gong MY, Zhou XX, Li ST, Wang BY. Improving effects of SSF on memory deficits and pathological changes of neural and immunological systems in senescent mice. Acta Pharmacol Sin 2001; 22(12): 1078-83.
[PMID: 11749803]
[9]
Cheng JJ, Zhao HX, Guo K, et al. Flavonoid from Scutellaria stems and leaves attenuates composited Aβ-induced memory impairment and apoptosis in rats. Zhongguo Xin Yao Zazhi 2016; 25(22): 2627-36.
[10]
Gao Y, Ma S, Shang YZ. Effect of Scutellaria baicalensis stem and leaf flavonoids on the intervention of okadaic acid-induced phosphorylation sites of Tau in rat cerebral cortex. Acta Neuropharmacol 2018; 8(6): 30-1.
[11]
Wang XQ, Gao Y, Dong YC, et al. Flavonoids from stem and leaf of Scutellaria baicalonsis Georgi inhibit PHF abnormality and regulatory mechanism of protein phosphatase in rats’ brain induced by okadaic acid. Chin J Pathophysi 2018; 34(1): 94-100.
[12]
Paxinos G. Charles Watson The rat brain in stereotaxic coordinates. Academic Press 2007.
[13]
Wu XG, Wang SS, Miao H, Cheng JJ, Zhang SF, Shang YZ. Scutellaria barbata flavonoids alleviate memory deficits and neuronal injuries induced by composited Aβ in rats. Behav Brain Funct 2016; 12(1): 33-43.
[http://dx.doi.org/10.1186/s12993-016-0118-8] [PMID: 27931218]
[14]
Alzheimer’s Disease International (ADI).World Alzheimer Report 2019: attitudes to dementia. London: ADI 2019; pp. 1-160.
[15]
Ritchie C, Smailagic N, Noel-Storr AH, Ukoumunne O, Ladds EC, Martin S. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2017; 3(3): CD010803.
[http://dx.doi.org/10.1002/14651858.CD010803.pub2] [PMID: 28328043]
[16]
Frozza RL, Horn AP, Hoppe JB, et al. A comparative study of beta-amyloid peptides Abeta1-42 and Abeta25-35 toxicity in organotypic hippocampal slice cultures. Neurochem Res 2009; 34(2): 295-303.
[http://dx.doi.org/10.1007/s11064-008-9776-8] [PMID: 18686032]
[17]
Kawahara M, Kato M, Kuroda Y. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res Bull 2001; 55(2): 211-7.
[http://dx.doi.org/10.1016/S0361-9230(01)00475-0] [PMID: 11470317]
[18]
Fang F, Yan Y, Feng ZH, et al. Study of Alzheimer’s disease animal model induced by multiple factors. Chongqing Med 2007; 36(2): 146-51.
[19]
De Felice FG, Wu D, Lambert MP, et al. Alzheimer’s disease- type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol Aging 2008; 29(9): 1334-47.
[http://dx.doi.org/10.1016/j.neurobiolaging.2007.02.029] [PMID: 17403556]
[20]
Matsuo ES, Shin RW, Billingsley ML, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer’s disease paired helical filament tau. Neuron 1994; 13(4): 989-1002.
[http://dx.doi.org/10.1016/0896-6273(94)90264-X] [PMID: 7946342]
[21]
Qian HY, Xiao YS, Hou JH, et al. Mechanism of Huangjingwan on inhibition of Tau hyperphosphorylation in hippocampal neurons of mice with Alzheimer’s disease which induced by D-galactose and okadaic acid resulting in learning and memory disorders. Chin J Exp Trad Med Formul 2020; 18(71): 1-12.
[22]
Šimić G, Babić Leko M, Wray S, et al. Tau protein hyperphosphorylation and aggregation in Alzheimer’s disease and other tauopathies, and possible neuroprotective strategies. Biomolecules 2016; 6(1): 6.
[http://dx.doi.org/10.3390/biom6010006] [PMID: 26751493]
[23]
Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, Trojanowski JQ. Total and phosphorylated tau protein as biological markers of Alzheimer’s disease. Exp Gerontol 2010; 45(1): 30-40.
[http://dx.doi.org/10.1016/j.exger.2009.10.010] [PMID: 19853650]
[24]
Chen YQ, Tian XH, Jia BQ, et al. Abnormal phosphorylation of Tau protein in Alzheimer’s disease and its mechanism. J Brain Nervous Dis 2019; 27(10): 645-50.
[25]
Kimura T, Sharma G, Ishiguro K, Hisanaga SI. Phospho-tau bar code: Analysis of phosphoisotypes of tau and its application to tauopathy. Front Neurosci 2018; 12: 44.
[http://dx.doi.org/10.3389/fnins.2018.00044] [PMID: 29467609]
[26]
Wang JZ, Xia YY, Grundke-Iqbal I, et al. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 2013; 123-39.
[http://dx.doi.org/10.3233/JAD-2012-129031]
[27]
Muntané G, Dalfó E, Martinez A, Ferrer I. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related alpha-synucleinopathies. Neuroscience 2008; 152(4): 913-23.
[http://dx.doi.org/10.1016/j.neuroscience.2008.01.030] [PMID: 18343584]
[28]
Hanger DP, Anderton BH, Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 2009; 15(3): 112-9.
[http://dx.doi.org/10.1016/j.molmed.2009.01.003] [PMID: 19246243]
[29]
Hou XC, Wang CZ, Wang ZY, et al. Scutellaria barbata flavonoids inhibit the abnormal generation of Aβ and NFT in brain and affect the related enzymes expression induced by composited Aβ in rats. Zhongguo Xin Yao Zazhi 2017; 26(18): 2218-24.
[30]
Ma S, Gao Y, Shang YZ. The effect of flavonoids of Scutellaria barbata flavonoids the brain Tau hyperphosphorylation at multiple sites induced by composited Aβ. Acta Neuropharmacologica 2018; 8(06): 47-8.
[31]
Cho JH, Johnson GV. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau’s ability to bind and stabilize microtubules. J Neurochem 2004; 88(2): 349-58.
[http://dx.doi.org/10.1111/j.1471-4159.2004.02155.x] [PMID: 14690523]
[32]
Broetto N, Hansen F, Brolese G, et al. Intracerebroventricular administration of okadaic acid induces hippocampal glucose uptake dysfunction and tau phosphorylation. Brain Res Bull 2016; 124: 136-43.
[http://dx.doi.org/10.1016/j.brainresbull.2016.04.014] [PMID: 27108544]
[33]
Ding H, Matthews TA, Johnson GV. Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation. J Biol Chem 2006; 281(28): 19107-14.
[http://dx.doi.org/10.1074/jbc.M511697200] [PMID: 16687396]
[34]
Babulal GM, Johnson A, Fagan AM, Morris JC, Roe CM. Identifying preclinical Alzheimer’s disease using everyday driving behavior: proof of concept. J Alzheimers Dis 2021; 79(3): 1009-14.
[http://dx.doi.org/10.3233/JAD-201294] [PMID: 33361605]
[35]
Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative accuracy of plasma phospho-tau 217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 2020; 324(8): 772-81.
[http://dx.doi.org/10.1001/jama.2020.12134] [PMID: 32722745]
[36]
Cavedo E, Lista S, Khachaturian Z, et al. The road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations. J Prev Alzheimers Dis 2014; 1(3): 181-202.
[PMID: 26478889]
[37]
Zhang H, Ding SK, Liu QQ, et al. Ca2+-Camk-CREB mediates the effect of flavonoids from Scutellaria baicalensis stems and leaves on the decrease of neuroregeneration induced by composited Aβ in rats. LJMPNP 2019; 5: 18-28.

Rights & Permissions Print Cite
Article Metrics
43
3
© 2024 Bentham Science Publishers | Privacy Policy